Incidence Rates of the Primary Brain Tumours in Georgia--a Population-based Study
Overview
Affiliations
Background: To determine the incidence rate and to describe other basic epidemiological data of primary brain tumours in a population-based study in Georgia, performed between March 2009 and March 2011.
Methods: Active case ascertainment was used to identify brain tumour cases by searching neuroradiology scan reports and medical records from all participating medical institutions, covering almost 100% of the neurooncology patients in the country.
Results: A total of 980 new cases were identified during the two-year period. For a population of almost 4.5 million, the overall annual incidence rate was 10.62 per 100,000 person-years, age-standardized to the year 2000 US population (ASR). Non-malignant tumours constituted about 65.5% of all tumours. Males accounted for 44% and females for 56% of the cases. Among classified tumours, age-standardized incidence rates by histology were highest for meningiomas (2.65/100,000), pituitary adenoma (1.23/100,000) and glioblastomas (0.51/100,000). ASR were higher among females than males for all primary brain tumours (10.35 vs. 9.48/100,000) as well as for main histology groups except for neuroepithelial, lymphomas and germ cell tumours.
Conclusions: The annual incidence rate of all primary brain tumours in Georgia, though comparable with some European registry data, is low in comparison with the 2004-2005 Central Brain Tumor Registry of the United States (CBTRUS) database, which may reflect variations in reporting and methodology. The higher percentage of unclassified tumours (37.8%) probably also affects the discrepancies between our and CBTRUS findings. However, the most frequently reported tumour was meningioma with a significant predominance in females, which is consistent with CBTRUS data.
Abuawad M, Daqour A, Alkaiyat A, Rjoub A, Zahra W, Issa N BMC Neurol. 2024; 24(1):168.
PMID: 38783212 PMC: 11112926. DOI: 10.1186/s12883-024-03677-1.
Trends in the Management Paradigms of Intracranial Meningioma.
Aljuboori Z, Alhourani A, Woo S, Hattab E, Yusuf M, Nelson M J Neurol Surg B Skull Base. 2021; 82(2):208-215.
PMID: 33777636 PMC: 7987396. DOI: 10.1055/s-0039-1697036.
Wanner M, Rohrmann S, Korol D, Shenglia N, Gigineishvili T, Gigineishvili D J Neurooncol. 2020; 149(2):273-282.
PMID: 32813185 PMC: 7541360. DOI: 10.1007/s11060-020-03595-5.
Ekinovic N, Beculic H, Skomorac R, Jusic A, Masovic A, Kurtagic D Medeni Med J. 2020; 35(2):136-141.
PMID: 32733763 PMC: 7384511. DOI: 10.5222/MMJ.2020.97415.
Song X, Zeng C, Wang M, Wang W, Lin F, He Q Neurosurg Rev. 2019; 44(1):389-400.
PMID: 31848767 DOI: 10.1007/s10143-019-01217-x.